Antiphospholipid syndrome (APS) is a condition wherein the immune system mistakenly attacks normal proteins in the blood resulting in the formation of blood clots within the veins or arteries in the legs (deep vein thrombosis) and internal organs such as the lungs and kidneys. These blood clots can also form in the brain and can result in stroke. APS also causes pregnancy-related complications that increase the risk of preeclampsia and preterm delivery. The condition can be either primary or secondary. It is the former if the underlying cause is unknown and the latter if it exists with another autoimmune disorder such as systemic lupus erythematosus (SLE).
Patients with APS normally suffer from various symptoms including pain and swelling in the arm or leg and vaginal spotting or bleeding during pregnancy. They can also suffer from symptoms of stroke, pulmonary embolism, and deep vein thrombosis. Since the condition poses life-threatening risks, it is crucial for patients to get diagnosed and treated as soon as possible.
Patients with antiphospholipid syndrome can take advantage of comprehensive medical care offered by world-class hospitals and clinics in Southeast Asian countries such as Singapore, Malaysia, and Thailand. Many hospitals, particularly those that are accredited by international organisations, such as Joint Commission International (JCI) and International Standards Organisation (ISO), are fully equipped to provide accurate diagnosis and targeted treatment. These hospitals, which feature world-class facilities and advanced technologies and laboratories, are staffed by highly trained medical professionals and specialists who bring to the table many years of experience and expertise. Many of them were educated in Western countries and trained in advanced methods and techniques so they are able to deliver improved patient outcomes.